Paris – Paul Hastings (Europe) LLP has advised the exiting shareholders of the Carso Group (Vendôme Parc Participations, EMZ, RAISE, Siparex, Unigrains and Etoile Capital) in connection with the LBO on the Carso Group, structured by ArchiMed.

With more than 2,600 employees in France, the Carso Group is a leading French player in the field of analytical services, such as testing, inspection, certification and bioanalysis for a wide range of industries, including water, health, construction, food, energy, agriculture and pharmaceuticals.

On this transaction, the Paul Hastings team was led by Olivier Deren and Sébastien Crepy (partners) and included Amaury Steinlin (associate) on the corporate aspects, Allard de Waal (partner) and Alban Castarède (associate) on the tax aspects, Stéphane Henry (partner) and Alexandre Ruiz (associate) on the employment law aspects, and Camille Paulhac (partner) and Juliette Hua (associate) on the antitrust aspects.

Tikehau, which provided the unitranche financing, was advised by Paul Hastings' financing team (Olivier Vermeulen and Marc Zerah, partners, and Louis Rivayrand, associate).

ArchiMed was advised by Dechert (Alain Decombe and Delphin Boucher, partners, and Vianney Toulouse, associate).

About Paul Hastings

At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.